ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
暂无分享,去创建一个
K. Sugimachi | K. Sugio | T. Inoue | T. Sasazuki | T. Ishida | K. Sugimachi | H. Yokoyama | Takashi Inoue
[1] S. Steinberg,et al. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. , 1991, Cancer research.
[2] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[3] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[4] R. Katakura,et al. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.
[5] S. Rodenhuis,et al. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. , 1991, Journal of the National Cancer Institute.
[6] J. Bishop. Molecular themes in oncogenesis , 1991, Cell.
[7] C. Marshall. Tumor suppressor genes , 1991, Cell.
[8] L. Cantley,et al. Oncogenes and signal transduction , 1991, Cell.
[9] J. Minna,et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.
[10] S. Rodenhuis,et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.
[11] S. Hirohashi,et al. Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.
[12] K. Sugio,et al. K‐ras activation in colorectal tumors from patients with familial polyposis coli , 1990, Cancer.
[13] T. Sekiya,et al. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1990, Oncogene.
[14] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[15] C. Bartram,et al. High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas , 1989, International journal of cancer.
[16] S. Rodenhuis,et al. The molecular genetics of human lung cancer. , 1989, The European respiratory journal.
[17] N. Lemoine,et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. , 1989, Oncogene.
[18] S. Rodenhuis,et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.
[19] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[20] K. Sugio,et al. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. , 1988, Cancer research.
[21] G. Fleuren,et al. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. , 1988, Nucleic acids research.
[22] M. Sklar. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. , 1988, Cancer research.
[23] M. Sklar. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.
[24] S. Rodenhuis,et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.
[25] H. Mano,et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.
[26] C. Mountain,et al. A new international staging system for lung cancer. , 1987, Chest.
[27] J. Bos,et al. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. , 1986, Gene.
[28] C. Marshall,et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia , 1985, Nature.
[29] A. Zelenetz,et al. Transformation by subgenomic fragments of Rous sarcoma virus DNA , 1980, Cell.